Gene · 4593
Papers3,141
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
901 to 920 of 3,141
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Seronegative myasthenic crisis: a multicenter analysis. | J Neurol | 2022 | 35389099 | PubTator, text mining | PubMed |
| Case Report: Identification of Compound Heterozygous Mutations in a Patient With Late-Onset Glycogen Storage Disease Type II (Pompe Disease). | Front Neurol | 2022 | 35386406 | PubTator, text mining | PubMed |
| [Clinical characteristics and outcomes of myasthenia gravis patients with double positive antibodies against acetylcholine receptor and muscle-specific tyrosine kinase]. | Zhonghua Yi Xue Za Zhi | 2022 | 35385966 | PubTator, text mining | PubMed |
| Physical and functional interactome atlas of human receptor tyrosine kinases. | EMBO Rep | 2022 | 35384245 | PubTator, text mining | PubMed |
| Can the Ratio SUVmax of the Lesion/SUVmax of Mediastinal Tissues Guide the Choice of Surgical Access for the Resection of Thymic Epithelial Tumors? | Front Surg | 2022 | 35372481 | PubTator, text mining | PubMed |
| Factors affecting minimal manifestation status induction in myasthenia gravis. | Ther Adv Neurol Disord | 2022 | 35371293 | PubTator, text mining | PubMed |
| A Randomized Open-Labeled Trial of Methotrexate as a Steroid-Sparing Agent for Patients With Generalized Myasthenia Gravis. | Front Immunol | 2022 | 35371086 | PubTator, text mining | PubMed |
| Effect of Fufang Huangqi Decoction on the Gut Microbiota in Patients With Class I or II Myasthenia Gravis. | Front Neurol | 2022 | 35370890 | PubTator, text mining | PubMed |
| Internalization of Muscle-Specific Kinase Is Increased by Agrin and Independent of Kinase-Activity, Lrp4 and Dynamin. | Front Mol Neurosci | 2022 | 35370548 | PubTator, text mining | PubMed |
| Myasthenia Gravis: A Rare Neurologic Complication of Immune Checkpoint Inhibitor Therapy. | J Adv Pract Oncol | 2022 | 35369395 | PubTator, text mining | PubMed |
| Dermal exposure to synthetic musks: Human health risk assessment, mechanism, and control strategy. | Ecotoxicol Environ Saf | 2022 | 35367890 | PubTator, text mining | PubMed |
| The clinical need for clustered AChR cell-based assay testing of seronegative MG. | J Neuroimmunol | 2022 | 35366559 | PubTator, text mining | PubMed |
| How to manage MuSK antibody-positive myasthenic crisis during pregnancy? | Ideggyogy Sz | 2022 | 35357789 | PubTator, text mining | PubMed |
| Post-Infectious Autoimmunity in the Central (CNS) and Peripheral (PNS) Nervous Systems: An African Perspective. | Front Immunol | 2022 | 35356001 | PubTator, text mining | PubMed |
| Consider Myocarditis When Patients Treated with Immune Checkpoint Inhibitors Present with Ocular Symptoms. | Oncologist | 2022 | 35348772 | PubTator, text mining | PubMed |
| Mitochondrial dynamics and biogenesis indicators may serve as potential biomarkers for diagnosis of myasthenia gravis. | Exp Ther Med | 2022 | 35340870 | PubTator, text mining | PubMed |
| Moderate phenotype of a congenital myasthenic syndrome type 19 caused by mutation of the COL13A1 gene: a case report. | J Med Case Rep | 2022 | 35337379 | PubTator, text mining | PubMed |
| Transcription Regulation of Tceal7 by the Triple Complex of Mef2c, Creb1 and Myod. | Biology (Basel) | 2022 | 35336819 | PubTator, text mining | PubMed |
| Current Treatment of Myasthenia Gravis. | J Clin Med | 2022 | 35329925 | PubTator, text mining | PubMed |
| Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study. | Lancet Rheumatol | 2022 | 35317410 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4593/papers?page=46